Assessment of FDA pharmaceutical drug adverse event data to formulate conclusions on specific drugs. Major activities performed included writing migration code to import FDA drug adverse event into proprietary database, writing code to export data in a meaningful format to perform data analysis, and using industry accepted algorithms to identify trends.